[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

IL129162A0 - Method for purfiying GBS toxin/CM101 - Google Patents

Method for purfiying GBS toxin/CM101

Info

Publication number
IL129162A0
IL129162A0 IL12916297A IL12916297A IL129162A0 IL 129162 A0 IL129162 A0 IL 129162A0 IL 12916297 A IL12916297 A IL 12916297A IL 12916297 A IL12916297 A IL 12916297A IL 129162 A0 IL129162 A0 IL 129162A0
Authority
IL
Israel
Prior art keywords
purfiying
gbs toxin
gbs
toxin
purfiying gbs
Prior art date
Application number
IL12916297A
Other languages
English (en)
Original Assignee
Univ Vanderbilt
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Vanderbilt filed Critical Univ Vanderbilt
Publication of IL129162A0 publication Critical patent/IL129162A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/26—Preparation of nitrogen-containing carbohydrates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P1/00—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes
    • C12P1/04—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes by using bacteria
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/46—Streptococcus ; Enterococcus; Lactococcus

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
IL12916297A 1996-09-30 1997-09-30 Method for purfiying GBS toxin/CM101 IL129162A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/744,770 US5811403A (en) 1996-09-30 1996-09-30 Polysaccharide toxin from Group B β-hemolytic Streptococcus (GBS) having improved purity
PCT/US1997/017535 WO1998014603A1 (en) 1996-09-30 1997-09-30 Method for purifying gbs toxin/cm101

Publications (1)

Publication Number Publication Date
IL129162A0 true IL129162A0 (en) 2000-02-17

Family

ID=24993931

Family Applications (1)

Application Number Title Priority Date Filing Date
IL12916297A IL129162A0 (en) 1996-09-30 1997-09-30 Method for purfiying GBS toxin/CM101

Country Status (19)

Country Link
US (4) US5811403A (es)
EP (1) EP0932696B1 (es)
JP (2) JP2001504144A (es)
KR (1) KR20000048757A (es)
CN (1) CN1192115C (es)
AR (1) AR011238A1 (es)
AT (1) ATE284449T1 (es)
AU (1) AU4802697A (es)
BR (1) BR9712167A (es)
CA (1) CA2265696C (es)
DE (1) DE69731891T2 (es)
DK (1) DK0932696T3 (es)
ES (1) ES2235228T3 (es)
HK (1) HK1025602A1 (es)
HR (1) HRP970525A2 (es)
IL (1) IL129162A0 (es)
NO (1) NO991529L (es)
WO (1) WO1998014603A1 (es)
ZA (1) ZA978754B (es)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5811403A (en) * 1996-09-30 1998-09-22 Vanderbilt University Polysaccharide toxin from Group B β-hemolytic Streptococcus (GBS) having improved purity
US5981508A (en) * 1997-01-29 1999-11-09 Vanderbilt University Facilitation of repair of neural injury with CM101/GBS toxin
US5858991A (en) * 1997-01-29 1999-01-12 Vanderbilt University Facilitation of wound healing with CM101/GBS toxin
US6028060A (en) * 1997-01-29 2000-02-22 Vanderbilt University Treatment of chronic inflammatory diseases with CM101/GBS toxin
US6803448B1 (en) 1998-07-22 2004-10-12 Vanderbilt University GBS toxin receptor
AU5125799A (en) * 1998-07-22 2000-02-14 Vanderbilt University Gbs toxin receptor
US8609614B2 (en) * 1998-07-22 2013-12-17 Vanderbilt University GBS toxin receptor compositions and methods of use
CN100540675C (zh) * 2006-12-06 2009-09-16 云南沃森生物技术有限公司 一种使用Sepharose 4FF凝胶对细菌多糖进行纯化的方法
PL2115010T3 (pl) 2007-02-28 2012-07-31 Lipoxen Tech Limited Zmniejszanie zawartości endotoksyny w kwasach polisialowych
CN102757516B (zh) * 2012-08-03 2014-06-18 常州千红生化制药股份有限公司 依诺肝素钠的脱色方法
US10905783B2 (en) 2015-11-27 2021-02-02 Michal RIVLIN Glucosamine and derivatives thereof in imaging
CN114702558B (zh) * 2022-04-06 2023-09-15 四川奥邦投资有限公司 一种新型葡甘杂聚糖肽及其制备方法与应用

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS557014A (en) * 1978-06-29 1980-01-18 Chugai Pharmaceut Co Ltd Antitumor agent and its preparation
JPS5740503A (en) * 1980-08-22 1982-03-06 Seikagaku Kogyo Co Ltd Separation of saccharides
US5059654A (en) * 1983-02-14 1991-10-22 Cuno Inc. Affinity matrices of modified polysaccharide supports
US4882317A (en) * 1984-05-10 1989-11-21 Merck & Co., Inc. Covalently-modified bacterial polysaccharides, stable covalent conjugates of such polysaccharides and immunogenic proteins with bigeneric spacers and methods of preparing such polysaccharides and conjugataes and of confirming covalency
US5302386A (en) * 1986-04-16 1994-04-12 Brigham And Women's Hospital, Inc. Bacterial antigens, antibodies, vaccines and methods of manufacture
US4771128A (en) * 1986-10-10 1988-09-13 Cetus Corporation Method of purifying toxin conjugates using hydrophobic interaction chromatography
US5094960A (en) * 1988-10-07 1992-03-10 New York Blood Center, Inc. Removal of process chemicals from labile biological mixtures by hydrophobic interaction chromatography
US5050062A (en) * 1989-02-06 1991-09-17 Hass David N Temperature controlled fluid system
US5010062A (en) 1989-09-25 1991-04-23 Vanderbilt University Therapeutic agent and method of inhibiting vascularization of tumors
US5225331A (en) * 1991-04-25 1993-07-06 National Research Council Of Canada Immunoassay for detecting group b streptococcus
GB9206291D0 (en) * 1992-03-23 1992-05-06 Cancer Res Campaign Tech Oligosaccharides having growth factor binding affinity
US5811403A (en) * 1996-09-30 1998-09-22 Vanderbilt University Polysaccharide toxin from Group B β-hemolytic Streptococcus (GBS) having improved purity

Also Published As

Publication number Publication date
CA2265696C (en) 2009-12-08
ZA978754B (en) 1998-03-23
US5811403A (en) 1998-09-22
HK1025602A1 (en) 2000-11-17
HRP970525A2 (en) 1998-08-31
EP0932696B1 (en) 2004-12-08
CN1192115C (zh) 2005-03-09
US6407069B1 (en) 2002-06-18
JP2001504144A (ja) 2001-03-27
KR20000048757A (ko) 2000-07-25
US5939396A (en) 1999-08-17
BR9712167A (pt) 2000-01-18
WO1998014603A1 (en) 1998-04-09
CN1235642A (zh) 1999-11-17
NO991529D0 (no) 1999-03-29
AU4802697A (en) 1998-04-24
ES2235228T3 (es) 2005-07-01
DE69731891T2 (de) 2005-12-01
DE69731891D1 (de) 2005-01-13
NO991529L (no) 1999-05-19
EP0932696A1 (en) 1999-08-04
JP2009173945A (ja) 2009-08-06
US6136789A (en) 2000-10-24
ATE284449T1 (de) 2004-12-15
CA2265696A1 (en) 1998-04-09
AR011238A1 (es) 2000-08-16
DK0932696T3 (da) 2005-03-14

Similar Documents

Publication Publication Date Title
HU9701136D0 (en) Synchronizing method
GB9600464D0 (en) Novel method
PL328976A1 (en) Tobacco swelling method
GB9521447D0 (en) Method
ZA974265B (en) Method for preservation
IL129162A0 (en) Method for purfiying GBS toxin/CM101
GB2289946B (en) Method
GB9619856D0 (en) Channel forming method
GB9619758D0 (en) Method
GB9417135D0 (en) Method
AU3746397A (en) Tempering method
GB9605709D0 (en) Method
GB9624822D0 (en) Method
GB9400227D0 (en) Validation method
GB9605482D0 (en) Method
GB9604465D0 (en) Novel method
GB9424723D0 (en) Method
EP0763802A3 (de) Verfahren zur psychometrischen Authentierung
GB9619759D0 (en) Method
GB9401566D0 (en) Method
AU2198997A (en) Method for treating insomnia
GB9611473D0 (en) Method
HU9601542D0 (en) Method
GB9619131D0 (en) Method
GB9617509D0 (en) Method